Addressing global health challenges: the pharmaphorum podcastFor episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to Share XAddressing global health challenges: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/iavi-global-health-challenges/
Huntsworth picks Annabelle Sandeman for global strategy roleAnnabelle Sandeman has been appointed as the new global head of commercial strategy at London-based healthcare and communications Share XHuntsworth picks Annabelle Sandeman for global strategy rolehttps://pharmaphorum.com/news/huntsworth-health-annabelle-sandeman/
Gene therapy and market access: the pharmaphorum podcastFor episode 10 of the pharmaphorum podcast I spoke to Nicola Redfern, who’s general manager at bluebird bio Share XGene therapy and market access: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/gene-therapy-market-access
UDG Healthcare acquires Putnam Associates and Incisive HealthUDG Healthcare has boosted its Ashfield Communications and Advisory business with a brace of deals, acquiring Putnam Associates Share XUDG Healthcare acquires Putnam Associates and Incisive Healthhttps://pharmaphorum.com/news/udg-healthcare-putnam-incisive-health/
Digital health goes global and continues to grow upHow to deal with new and emerging technologies is an ongoing problem for healthcare stakeholders, who often struggle Share XDigital health goes global and continues to grow uphttps://pharmaphorum.com/digital/digital-health-guidelines-growth/
AMR research and Matoke Pharma: the pharmaphorum podcastRe-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a Share XAMR research and Matoke Pharma: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/amr-research-matoke-pharma-podcast/
Engaging HCPs through digital mediaThe ubiquity of digital technology allows pharma reps to communicate with healthcare professionals (HCPs) through their preferred channels, Share XEngaging HCPs through digital mediahttps://pharmaphorum.com/views-analysis-sales-marketing/engaging-hcps-through-digital-media/
FDA approves first medical device ADHD treatmentUS regulators have given the green-light for the first medical device to treat attention deficit hyperactivity disorder (ADHD). Share XFDA approves first medical device ADHD treatmenthttps://pharmaphorum.com/news/fda-approves-neurosigma-adhd/
The Bloc promotes Jennifer Matthews to CEO and presidentNew York-based healthcare creative agency The Bloc has promoted managing partner Jennifer Matthews to CEO and president. It’s Share XThe Bloc promotes Jennifer Matthews to CEO and presidenthttps://pharmaphorum.com/news/the-bloc-promotes-jennifer-matthews-ceo/
